Literature DB >> 19890128

Normal spermatogenesis in a man with mutant luteinizing hormone.

Caroline Achard1, Carine Courtillot, Olivier Lahuna, Géri Méduri, Jean-Claude Soufir, Philippe Lière, Anne Bachelot, Hassani Benyounes, Michael Schumacher, Frédérique Kuttenn, Philippe Touraine, Micheline Misrahi.   

Abstract

Men with mutations in LHB, the gene encoding the beta subunit of luteinizing hormone (LHB), have azoospermia with absent or few fetal Leydig cells. We report a mutation in LHB in a man and his sister. The man presented with absence of virilization, undetectable luteinizing hormone, and a low serum testosterone level. He had complete spermatogenesis with a normal sperm count. The mutant luteinizing hormone had a low level of partial activity in vitro. We concluded that the residual luteinizing hormone activity, resulting in the expression of steroidogenic enzymes in few mature Leydig cells producing small amounts of intratesticular testosterone (20.2 ng per gram), was sufficient for complete and quantitatively normal spermatogenesis. Copyright 2009 Massachusetts Medical Society.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19890128     DOI: 10.1056/NEJMoa0805792

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  16 in total

Review 1.  Endocrine control of spermatogenesis: Role of FSH and LH/ testosterone.

Authors:  Suresh Ramaswamy; Gerhard F Weinbauer
Journal:  Spermatogenesis       Date:  2015-01-26

2.  The long-term clinical follow-up and natural history of men with adult-onset idiopathic hypogonadotropic hypogonadism.

Authors:  Andrew A Dwyer; Frances J Hayes; Lacey Plummer; Nelly Pitteloud; William F Crowley
Journal:  J Clin Endocrinol Metab       Date:  2010-06-30       Impact factor: 5.958

Review 3.  Hormonal therapy for non-obstructive azoospermia: basic and clinical perspectives.

Authors:  Koji Shiraishi
Journal:  Reprod Med Biol       Date:  2014-09-18

4.  Homozygous nonsense mutation Trp28X in the LHB gene causes male hypogonadism.

Authors:  Xiaoyu Yang; H Ochin; Li Shu; Jinyong Liu; Jiandong Shen; Jiayin Liu; Changsong Lin; Yugui Cui
Journal:  J Assist Reprod Genet       Date:  2018-02-23       Impact factor: 3.412

Review 5.  Possible therapeutic use of spermatogonial stem cells in the treatment of male infertility: a brief overview.

Authors:  Slobodan Vlajković; Rade Cukuranović; Marija Daković Bjelaković; Vladisav Stefanović
Journal:  ScientificWorldJournal       Date:  2012-03-12

6.  Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations.

Authors:  Eeva-Maria Laitinen; Johanna Tommiska; Timo Sane; Kirsi Vaaralahti; Jorma Toppari; Taneli Raivio
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

Review 7.  Genetic Models for the Study of Luteinizing Hormone Receptor Function.

Authors:  Prema Narayan
Journal:  Front Endocrinol (Lausanne)       Date:  2015-09-29       Impact factor: 5.555

8.  The consequences of mutations in the reproductive endocrine system.

Authors:  Donchan Choi
Journal:  Dev Reprod       Date:  2012-12

Review 9.  Luteinizing hormone and human chorionic gonadotropin: distinguishing unique physiologic roles.

Authors:  Janet Choi; Johan Smitz
Journal:  Gynecol Endocrinol       Date:  2013-11-27       Impact factor: 2.260

Review 10.  Reproduction, smell, and neurodevelopmental disorders: genetic defects in different hypogonadotropic hypogonadal syndromes.

Authors:  Hernan Valdes-Socin; Matilde Rubio Almanza; Mariana Tomé Fernández-Ladreda; François Guillaume Debray; Vincent Bours; Albert Beckers
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-09       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.